JEST
PRME icon

JTC Employer Solutions Trustee’s Prime Medicine PRME Stock Holding History

JTC Employer Solutions Trustee’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$49K Hold
13,249
– – ﹤0.01% 249
2026
Q1 		$46K Hold
13,249
– – ﹤0.01% 244
2025
Q4 		$46K Hold
13,249
– – ﹤0.01% 250
2025
Q3 		$73K Hold
13,249
– – 0.01% 226
2025
Q2 		$33K Buy
+13,249
New +$20.4K ﹤0.01% 247

Other funds holding PRME

Alphabet Inc
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ARK Investment Management
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Woodline Partners
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

JTC Employer Solutions Trustee's PRME Position: Q2 2026 in Review

JTC Employer Solutions Trustee held its Prime Medicine (PRME) position steady in Q2 2026 at 13,249 shares worth $49K. The position accounts for ﹤0.01% of the portfolio, ranked #249.

JTC Employer Solutions Trustee first reported a position in PRME in Q2 2025 and has held it in 5 quarters since. The position peaked at $73K in Q3 2025. 187 funds tracked by Wall St. Rank hold PRME as of Q2 2026.

  • JTC Employer Solutions Trustee held 13,249 shares of Prime Medicine worth $49K as of Q2 2026.
  • JTC Employer Solutions Trustee left its Prime Medicine share count unchanged in Q2 2026.
  • Prime Medicine made up ﹤0.01% of JTC Employer Solutions Trustee's portfolio in Q2 2026, its #249 holding.
  • JTC Employer Solutions Trustee first reported a position in Prime Medicine in Q2 2025 and has held it in 5 quarters since.
  • JTC Employer Solutions Trustee's Prime Medicine position peaked at $73K in Q3 2025.
  • 187 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2026.

Based on JTC Employer Solutions Trustee's 13F filing for Q2 2026, filed 31 Jul 2026.